Neuroepidemiology Unit Centre for Epidemiology and Biostatistics Melbourne School of Population and Global Health Faculty of Medicine, Dentistry and Health Sciences The University of Melbourneread more
International Progressive MS Alliance e-News - March 2021 In this issue: • Read about the recent call to action to prioritise research on symptoms that matter most to people affected…read more
Access Advisors provides digital accessibility consultance services around the country. They also regularly recruit people with access needs who are interested in doing research for some of the more enlightened…read more
A survey exploring participants’ perspectives of people living with Multiple Sclerosis to better understand adjustment to diagnosis and the role of psychological support in the patient journey.read more
Karen Oldfield is a Doctoral student in Clinical Research at Victoria University of Wellington and Medical Research Fellow at the Medical Research Institute of New Zealand. Her PhD is exploring…read more
Can you help Researchers understand more about the psychological support needed following an MS diagnosis?read more
MSIF and the MS Data Alliance, have launched a COVID-19 and MS global data-sharing initiativeread more
Questionnaire for persons with multiple sclerosis: language, communication, and quality of liferead more
You are invited to take part in a study, exploring your views on the value of a telehealth complex-wheelchair assessment service.read more
A small clinical trial of clemastine fumarate, a common, over-the-counter allergy medication, has been conducted in people with MS and has shown exciting evidence for myelin repair.read more
A significant portion of people with MS will experience falls, with research showing that in the previous six months up to 60% of people with MS will have fallen. A…read more
MIS416, a potential therapy for secondary progressive MS, has recently finished undergoing phase 2 trials here in Australia and New Zealand. Now Innate Immunotherapeutics, the New Zealand biotech company behind…read more
The last decade has seen the development of a number of new treatments for relapsing forms of MS. Unfortunately, there hasn’t been the same progress in treating progressive forms of…read more
Canadian researchers have presented preliminary results of a clinical trial that suggests a surgical intervention to unblock the veins draining the brain and spinal cord is not effective in treating…read more
The full clinical trial results have been published for ocrelizumab (Ocrevus®), a new treatment option for primary progressive MS and relapsing MS.read more
There is a lot of interest in the MS community in the potential treatment option for MS known as autologous haematopoietic stem cell transplant (AHSCT). Research into this form of…read more
